跳至主要内容
临床试验/IRCT20190911044744N4
IRCT20190911044744N4已完成3 期

Evaluation of the effectiveness of curcumin in the prevention of contrast induced nephropathy in following coronary Angiography: A randomized controlled Trial

Yazd University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Age 18 years and older
  • Hospitalized in Afshar Yazd Hospital, who is undergoing coronary angioplasty as a non-emergency.
  • not receiving nephrotoxic drugs.
  • not taking curcumin containing drugs in the past one month and no history of allergic reaction after taking oral curcumin
  • Hospitalization in the cardiac intensive care unit for 2 days Informed consent of the patient himself or his legal guar
  • Informed consent of the patient himself or his legal guardian.

排除标准

  • Pregnant or lactating women
  • Allergy to curcumin
  • Receiving nephrotoxic drugs

研究者

发起方
Yazd University of Medical Sciences

相似试验